All subjects who are still on study treatment at that time will enter the OL Extension Phase (either the Treatment Period or Follow-Up Period). In the OL Extension Treatment Period, the subjects will be allowed to receive active treatment if they were randomized in the placebo arm. During the OL Follow-up Period, all subjects will continue to be followed for QoL survival and all subsequent anticancer treatments received will be recorded.